FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3191929620> ?p ?o ?g. }

• W3191929620 abstract "Background: Schizophrenia is one of the most serious mental disorders presenting in adolescence. Antipsychotic drugs are the basis of treatment and clinical management of patients with schizophrenia. Despite the efficacy of risperidone as one of the antipsychotic drugs, about two-thirds of patients may experience both positive and negative symptoms during their life. Objectives: We evaluated the efficacy of galantamine as an adjunctive treatment for ameliorating the negative symptoms of schizophrenia patients. Methods: This is a randomized double-blind phase II clinical trial study carried out on schizophrenia patients admitted to a psychiatric department. The patients were randomly divided into two equal groups using the block randomization method. The intervention group received 24 mg galantamine plus 2 - 6 mg risperidone, and controls received 24 mg placebo along with 2 - 6 mg risperidone. Neurological tests included the Scale for the Assessment of Negative Symptoms (SANS) and the Positive and Negative Syndrome Scale (PANSS) at baseline and weeks 2, 4, and 8 after treatment. Results: We studied 28 patients. The mean age of the participants was 44 ± 3.1 and 47 ± 2.7 years in the placebo and intervention groups, respectively. The PANSS score significantly decreased over study time. The intervention group showed significantly greater reduction slopes than the control group (P = 0.034). Alogia (P = 0.0016) and attention (P = 0.0108) reduced more intensely in the intervention group than in the control group. Conclusions: Our findings indicated that galantamine could significantly affect the severity of the symptoms of schizophrenia patients. The findings suggest galantine as an appropriate adjunctive treatment for ameliorating negative symptoms, especially attention and alogia." @default.
• W3191929620 created "2021-08-16" @default.
• W3191929620 creator A5042648094 @default.
• W3191929620 creator A5061079054 @default.
• W3191929620 creator A5071010968 @default.
• W3191929620 creator A5083372464 @default.
• W3191929620 date "2021-08-09" @default.
• W3191929620 modified "2023-09-24" @default.
• W3191929620 title "Galantamine as Adjunctive Treatment for Ameliorating Negative Symptoms of Schizophrenia Patients" @default.
• W3191929620 cites W1694864989 @default.
• W3191929620 cites W1983457306 @default.
• W3191929620 cites W2010745232 @default.
• W3191929620 cites W2011852864 @default.
• W3191929620 cites W2018486737 @default.
• W3191929620 cites W2063765492 @default.
• W3191929620 cites W2069500547 @default.
• W3191929620 cites W2070230912 @default.
• W3191929620 cites W2077887990 @default.
• W3191929620 cites W2086583079 @default.
• W3191929620 cites W2095247527 @default.
• W3191929620 cites W2120049254 @default.
• W3191929620 cites W2134262474 @default.
• W3191929620 cites W2135880942 @default.
• W3191929620 cites W2156601000 @default.
• W3191929620 cites W2166537930 @default.
• W3191929620 cites W2166739899 @default.
• W3191929620 cites W2397275057 @default.
• W3191929620 cites W2624006781 @default.
• W3191929620 cites W2724675654 @default.
• W3191929620 cites W2901474638 @default.
• W3191929620 cites W2916950229 @default.
• W3191929620 cites W2945524538 @default.
• W3191929620 cites W2099333405 @default.
• W3191929620 doi "https://doi.org/10.5812/jjcdc.114989" @default.
• W3191929620 hasPublicationYear "2021" @default.
• W3191929620 type Work @default.
• W3191929620 sameAs 3191929620 @default.
• W3191929620 citedByCount "1" @default.
• W3191929620 countsByYear W31919296202023 @default.
• W3191929620 crossrefType "journal-article" @default.
• W3191929620 hasAuthorship W3191929620A5042648094 @default.
• W3191929620 hasAuthorship W3191929620A5061079054 @default.
• W3191929620 hasAuthorship W3191929620A5071010968 @default.
• W3191929620 hasAuthorship W3191929620A5083372464 @default.
• W3191929620 hasBestOaLocation W31919296201 @default.
• W3191929620 hasConcept C118552586 @default.
• W3191929620 hasConcept C126322002 @default.
• W3191929620 hasConcept C142724271 @default.
• W3191929620 hasConcept C168563851 @default.
• W3191929620 hasConcept C204243189 @default.
• W3191929620 hasConcept C204787440 @default.
• W3191929620 hasConcept C27081682 @default.
• W3191929620 hasConcept C2776412080 @default.
• W3191929620 hasConcept C2779056891 @default.
• W3191929620 hasConcept C2779134260 @default.
• W3191929620 hasConcept C2779483572 @default.
• W3191929620 hasConcept C2779727114 @default.
• W3191929620 hasConcept C2780057945 @default.
• W3191929620 hasConcept C2780135775 @default.
• W3191929620 hasConcept C2780442968 @default.
• W3191929620 hasConcept C2780494398 @default.
• W3191929620 hasConcept C2780904820 @default.
• W3191929620 hasConcept C3018162438 @default.
• W3191929620 hasConcept C3019023267 @default.
• W3191929620 hasConcept C535046627 @default.
• W3191929620 hasConcept C71924100 @default.
• W3191929620 hasConceptScore W3191929620C118552586 @default.
• W3191929620 hasConceptScore W3191929620C126322002 @default.
• W3191929620 hasConceptScore W3191929620C142724271 @default.
• W3191929620 hasConceptScore W3191929620C168563851 @default.
• W3191929620 hasConceptScore W3191929620C204243189 @default.
• W3191929620 hasConceptScore W3191929620C204787440 @default.
• W3191929620 hasConceptScore W3191929620C27081682 @default.
• W3191929620 hasConceptScore W3191929620C2776412080 @default.
• W3191929620 hasConceptScore W3191929620C2779056891 @default.
• W3191929620 hasConceptScore W3191929620C2779134260 @default.
• W3191929620 hasConceptScore W3191929620C2779483572 @default.
• W3191929620 hasConceptScore W3191929620C2779727114 @default.
• W3191929620 hasConceptScore W3191929620C2780057945 @default.
• W3191929620 hasConceptScore W3191929620C2780135775 @default.
• W3191929620 hasConceptScore W3191929620C2780442968 @default.
• W3191929620 hasConceptScore W3191929620C2780494398 @default.
• W3191929620 hasConceptScore W3191929620C2780904820 @default.
• W3191929620 hasConceptScore W3191929620C3018162438 @default.
• W3191929620 hasConceptScore W3191929620C3019023267 @default.
• W3191929620 hasConceptScore W3191929620C535046627 @default.
• W3191929620 hasConceptScore W3191929620C71924100 @default.
• W3191929620 hasIssue "3" @default.
• W3191929620 hasLocation W31919296201 @default.
• W3191929620 hasOpenAccess W3191929620 @default.
• W3191929620 hasPrimaryLocation W31919296201 @default.
• W3191929620 hasRelatedWork W1965870105 @default.
• W3191929620 hasRelatedWork W1975413208 @default.
• W3191929620 hasRelatedWork W1988482389 @default.
• W3191929620 hasRelatedWork W2118787204 @default.
• W3191929620 hasRelatedWork W2167059050 @default.
• W3191929620 hasRelatedWork W2327693359 @default.
• W3191929620 hasRelatedWork W2354670748 @default.
• W3191929620 hasRelatedWork W2373455425 @default.
• W3191929620 hasRelatedWork W3191929620 @default.

• next